๐”– Scriptorium
โœฆ   LIBER   โœฆ

๐Ÿ“

Structure-based drug design

โœ Scribed by Veerapandian


Publisher
Informa Healthcare
Year
1997
Tongue
English
Leaves
831
Edition
1
Category
Library

โฌ‡  Acquire This Volume

No coin nor oath required. For personal study only.

โœฆ Synopsis


Introducing the most recent advances in crystallography, nuclear magnetic resonance, molecular modeling techniques, and computational combinatorial chemistry, this unique, interdisciplinary reference explains the application of three-dimensional structural information in the design of pharmaceutical drugs. Furnishing authoritative analyses by world-renowned experts, Structure-Based Drug Design discusses protein structure-based design in optimizing HIV protease inhibitors and details the biochemical, genetic, and clinical data on HIV-1 reverse transcriptase presents recent results on the high-resolution three-dimensional structure of the catalytic core domain of HIV-1 integrase as a foundation for divergent combination therapy focuses on structure-based design strategies for uncovering receptor antagonists to treat inflammatory diseases demonstrates a systematic approach to the design of inhibitory compounds in cancer treatment reviews current knowledge on the Interleukin-1 (IL-1) system and progress in thedevelopment of IL-1 modulators describes the influence of structure-based methods in designing capsid-binding inhibitors for relief of the common cold and much more.


๐Ÿ“œ SIMILAR VOLUMES


Drug Design: Structure- and Ligand-Based
โœ Kenneth M. Merz (editor), Dagmar Ringe (editor), Charles H. Reynolds (editor) ๐Ÿ“‚ Library ๐Ÿ“… 2010 ๐Ÿ› Cambridge University Press ๐ŸŒ English

Structure-based (SBDD) and ligand-based (LBDD) drug design are extremely important and active areas of research in both the academic and commercial realms. This book provides a complete snapshot of the field of computer-aided drug design and associated experimental approaches. Topics covered include

Drug Design: Structure- and Ligand-Based
โœ Kenneth M. Merz, Dagmar Ringe, Charles H. Reynolds ๐Ÿ“‚ Library ๐Ÿ“… 2010 ๐Ÿ› Cambridge University Press ๐ŸŒ English

Structure-based (SBDD) and ligand-based (LBDD) drug design are extremely important and active areas of research in both the academic and commercial realms. This book provides a complete snapshot of the field of computer-aided drug design and associated experimental approaches. Topics covered include

Structure-Based Drug Design: Experimenta
โœ W. L. Duax, J. F. Griffin (auth.), Penelope W. Codding (eds.) ๐Ÿ“‚ Library ๐Ÿ“… 1998 ๐Ÿ› Springer Netherlands ๐ŸŒ English

<p><em>Structure-Based Drug Design</em> brings together scientists working on different aspects of the subject, demonstrating the necessary collaboration and interdisciplinary approach to this complex area. The focus is on X-ray crystallographic and computational approaches. The general aspects of t

Computer Aided Drug Design (CADD): From
โœ Mithun Rudrapal, Chukwuebuka Egbuna ๐Ÿ“‚ Library ๐Ÿ“… 2022 ๐Ÿ› Elsevier ๐ŸŒ English

<p><span>Computer-Aided Drug Design (CADD): From Ligand-Based Methods to Structure-Based Approaches</span><span> outlines the basic theoretical principles, methodologies and applications of different fundamental and advanced CADD approaches and techniques. Including information on current protocols

Structure-based Drug Discovery
โœ Harren Jhoti (Editor), Andrew Leach (Editor) ๐Ÿ“‚ Library ๐Ÿ“… 2007 ๐Ÿ› Springer ๐ŸŒ English

Discovering new medicines is becoming more challenging and the pharmaceutical industry is looking to new technologies to help in this mission. Structure-based drug discovery methods have been transformed in the last 5-10 years and are now having a major impact on the discovery of new drugs. Some of